Research Article

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias

Table 2

Time intervals (in minutes) for each step of ibutilide or DC-ECV cardioversion.

Group A: ibutilideGroup B: DC-ECV
Patient number1st infusion 𝑁 = 1 7 Time to CV 𝑁 = 1 7 2nd infusion 𝑁 = 4 Time to CV 𝑁 = 3 Total time 𝑁 = 1 6 Patient numberCall 𝑁 = 1 7 Preparation/
sedation 𝑁 = 1 7
Shock/
recovery 𝑁 = 1 7
2nd shock 𝑁 = 2 Total time 𝑁 = 1 7

Pt #1940013Pt #1275519
Pt #21060016Pt #2386017
Pt #3930012Pt #3385016
Pt #41030013Pt #4295016
Pt #51060016Pt #5294015
Pt #6920011Pt #6185014
Pt #71010011Pt #7187016
Pt #81090019Pt #83108021
Pt #91030013Pt #9284014
Pt #1010100020Pt #10496019
Pt #111030013Pt #1121212526
Pt #12930012Pt #12295016
Pt #131020012Pt #13394016
Pt #14101010333Pt #14397019
Pt #15101010232Pt #15374014
Pt #16101010Pt #16386017
Pt #17101010232Pt #17487019

Mean ±SD*9.75 ± 0.455.31 ± 3.3810.00 ± 0.02.33 ± 0.5817.37 ± 7.87Mean±SD2.53 ± 0.878.59 ± 1.185.88 ± 2.005.00 ± 0.0017.29 ± 3.04

*Group A (ibutilide) patient no. 16 is excluded from the calculation of mean time intervals because of failure to restore sinus rhythm. Total mean time did not differ significantly between groups ( 𝑃 = . 1 1 8 ).
DC-ECV: Direct current electrical cardioversion; CV: cardioversion.